Full Press Release Details
Lexaria s ViPovaTM Tea Available
Kelowna, BC / April 8, 2015 / Lexaria, Corp. (OTCQB:LXRP)
(CSE:LXX) (the Company ) is very pleased to announce that ViPovaTM
tea will soon be available for sale at Amazon.com and other online retailers.
We expect to have ViPova tea available for sale at the world s
largest online superstore. said Lexaria CEO Chris Bunka. We know we need to
make our products more widely available and we couldn t be more proud than to
start at the top, with the world s best online retailer.
Small businesses like ViPova, world-class retail brands, and
individual sellers increase their sales and reach new customers by leveraging
the power of the Amazon.com e-commerce platform. Amazon.com strives to be
Earth s most customer-centric company and serves consumers through a focus on
vast selection, price, and convenience. At peak times, Amazon USA sells as many
as 426 items per second, or 36.8 million items in a single day. Some reports
have indicated that 80-90 million Americans shop at Amazon.com every month.
During 2014, Amazon.com reported full year revenue of approx. $88.9 Billion.
Although not available at Amazon today, Lexaria believes it is
important to provide disclosure regarding this important pending development as
it would mark a potentially significant new sales channel, and availability at
Amazon.com should be imminent. Lexaria continues to open sales channels for its
ViPovaTM brand, making progress consistently as to the number of
online locations where consumers can access our premium products. These efforts
are ongoing and beginning to be productive.
As well, Lexaria has awarded an initial 6-month Search Engine
Optimization (SEO) contract designed to increase the visibility of its online
brands and support its online retailers and sellers. This SEO contract has
already commenced and is expected to provide steadily improved visibility in the
months to come, and will be part of our growing efforts to build brand
recognition and interest in our products.
Vipovatm encourages other retailers, either online
or brick-and-mortar, that wish to carry our ground-breaking products to contact
us by email at customerservice@vipova.com for distribution information.
Lexaria's shares are quoted in the USA with
symbol LXRP and in Canada with symbol LXX. The company searches for
opportunities that could provide potential above-market returns.
legal CBD oil extracts, grown from legal hemp in locations where it is legal to
do so, in ViPovaTM-branded tea. ViPovaTM uses its
patent-pending process to infuse concentrated amounts of CBD within lipids in
its tea, providing more bioactivity and comfort to the body during the
absorption process. Only ViPovaTM has this ground-breaking technology
for CBD/lipid infusion. www.vipova.com
FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements. Such forward-looking statements are
estimates reflecting the Company's best judgment based upon current information
and involve a number of risks and uncertainties, and there can be no assurance
that other factors will not affect the accuracy of such forward-looking
statements. Access to capital, or lack thereof, is a major risk and there is no
assurance that the Company will be able to raise required working capital.
Current oil and gas production rates may not be sustainable and targeted
production rates may not occur. Factors which could cause actual results to
differ materially from those estimated by the Company include, but are not
limited to, government regulation, managing and maintaining growth, the effect
of adverse publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements and filings.
There is no assurance that the medical marijuana, CBD sector, or alternative
health businesses will provide any benefit to Lexaria, or that the Company will
experience any growth through participation in these sectors. There is no
assurance that existing capital is sufficient for the Company's needs or that it
will need to attempt to raise additional capital. There is no assurance that any
planned corporate activity, business venture, or initiative will be pursued, or
if pursued, will be successful. There is no assurance that any cannabinoid-based
product will promote, assist, or maintain any beneficial human health conditions
whatsoever. No statement herein has been evaluated by the Food and Drug
Administration (FDA). ViPovaTM products are not intended to diagnose,
treat, cure or prevent any disease.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.